• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能受损对接受血运重建的慢性完全闭塞病变患者结局的影响:系统评价和荟萃分析。

Impact of impaired renal function on outcomes of chronic total occlusion undergoing revascularization: a systemic review and meta-analysis.

机构信息

Blood Purification Center of Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, No.19 Xiuhua Road, Xiuying District, Haikon City, Hianan Province, China.

Department of Cardiovascular Medicine, Sanya Peoples Hospital, West China Sanya Hospital of Sichuan University, No.558 Jiefang Road, Sanya City, Hainan Province, China.

出版信息

Int Urol Nephrol. 2022 Dec;54(12):3179-3191. doi: 10.1007/s11255-022-03192-7. Epub 2022 Jun 11.

DOI:10.1007/s11255-022-03192-7
PMID:35689780
Abstract

PURPOSE

Patients with chronic kidney disease (CKD) have an associated burden of coronary artery disease, including chronic total occlusions (CTO). It is unclear how the presence of CKD affects the outcomes of CTO revascularization. Previous reviews have not taken into account all relevant published studies that examined the association of CKD with outcomes of CTO revascularization.

METHODS

A systematic search was conducted using PubMed, Scopus, and Google Scholar databases for studies investigating patients with or without CKD who also had coronary chronic total occlusion undergoing revascularization procedures Statistical analysis was performed using STATA software. Effect sizes were reported as pooled relative risk (RR).

RESULTS

A total of 13 studies were included. CKD patients showed elevated risk of in-hospital mortality (RR 4.25, 95% CI 2.64, 6.82) and mortality at latest follow-up (RR 3.24, 95% CI 2.56, 4.11), elevated risk of major cardio or cerebrovascular events (RR 1.65, 95% CI 1.38, 1.98), major bleeding (RR 2.85, 95% CI 1.96, 4.13), and contrast-induced acute kidney injury (RR 3.06, 95% CI 1.70, 5.52). CKD patients also showed lower chances of technical success (RR 0.95, 95% CI 0.91, 1.00).

CONCLUSIONS

The presence of CKD increases the risk of mortality, complications and adversely affects the success of CTO revascularization. Patients with CKD undergoing revascularization should have their kidney function comprehensively evaluated and these patients should be carefully monitored.

摘要

目的

患有慢性肾脏病(CKD)的患者存在冠状动脉疾病负担,包括慢性完全闭塞(CTO)。目前尚不清楚 CKD 的存在如何影响 CTO 血运重建的结局。既往的综述没有考虑到所有相关的已发表研究,这些研究检查了 CKD 与 CTO 血运重建结局的关系。

方法

使用 PubMed、Scopus 和 Google Scholar 数据库系统地搜索了研究 CKD 患者或无 CKD 患者同时患有冠状动脉慢性完全闭塞并接受血运重建的研究。使用 STATA 软件进行统计分析。效应大小以汇总相对风险(RR)报告。

结果

共纳入 13 项研究。CKD 患者的住院死亡率(RR 4.25,95%CI 2.64,6.82)和随访时的死亡率(RR 3.24,95%CI 2.56,4.11)、主要心脑血管事件(RR 1.65,95%CI 1.38,1.98)、大出血(RR 2.85,95%CI 1.96,4.13)和对比剂诱导的急性肾损伤(RR 3.06,95%CI 1.70,5.52)的风险增加,技术成功率(RR 0.95,95%CI 0.91,1.00)降低。

结论

CKD 的存在增加了死亡率、并发症的风险,并对 CTO 血运重建的成功率产生不利影响。接受血运重建的 CKD 患者应全面评估其肾功能,并对这些患者进行仔细监测。

相似文献

1
Impact of impaired renal function on outcomes of chronic total occlusion undergoing revascularization: a systemic review and meta-analysis.肾功能受损对接受血运重建的慢性完全闭塞病变患者结局的影响:系统评价和荟萃分析。
Int Urol Nephrol. 2022 Dec;54(12):3179-3191. doi: 10.1007/s11255-022-03192-7. Epub 2022 Jun 11.
2
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
3
Impact of diabetes mellitus on all and successful percutaneous coronary intervention outcomes for chronic total occlusions: A systematic review and meta-analysis.糖尿病对慢性完全闭塞病变患者全因及经皮冠状动脉介入治疗成功结局的影响:系统评价和荟萃分析。
Heart Lung. 2022 Sep-Oct;55:108-116. doi: 10.1016/j.hrtlng.2022.04.010. Epub 2022 May 6.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
5
Impact of Diabetes Mellitus on Outcomes of Percutaneous Coronary Intervention in Chronic Total Occlusions: A Systematic Review and Meta-Analysis.糖尿病对慢性完全闭塞经皮冠状动脉介入治疗结局的影响:系统评价和荟萃分析。
Cardiovasc Revasc Med. 2022 Apr;37:68-75. doi: 10.1016/j.carrev.2021.06.017. Epub 2021 Jun 19.
6
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
7
Drug-Eluting vs Bare-Metal Stents in Patients With Chronic Kidney Disease and Coronary Artery Disease: Insights From a Systematic Review and Meta-Analysis.慢性肾脏病合并冠状动脉疾病患者使用药物洗脱支架与裸金属支架的比较:系统评价与荟萃分析的见解
J Invasive Cardiol. 2018 Jan;30(1):10-17. Epub 2017 Sep 15.
8
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis.一项系统评价、Meta分析和网状Meta分析表明,在慢性肾脏病患者中,药物洗脱支架在降低临床结局和支架相关并发症方面优于裸金属支架。
J Interv Cardiol. 2018 Jun;31(3):319-329. doi: 10.1111/joic.12473. Epub 2017 Dec 28.
9
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.多发性骨髓瘤患者接受免疫调节剂治疗时的门诊抗血栓治疗。
Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD014739. doi: 10.1002/14651858.CD014739.
10
Antiplatelet agents for chronic kidney disease.抗血小板药物在慢性肾脏病中的应用。
Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4.

引用本文的文献

1
Association of chronic kidney disease with postoperative outcomes: a national surgical quality improvement program (NSQIP) multi-specialty surgical cohort analysis.慢性肾脏病与术后结局的关联:国家外科质量改进计划(NSQIP)多专科外科队列分析。
BMC Nephrol. 2024 Sep 13;25(1):305. doi: 10.1186/s12882-024-03753-1.

本文引用的文献

1
In-hospital outcomes of patients with chronic kidney disease undergoing percutaneous coronary intervention for chronic total occlusion: a systematic review and meta-analysis.慢性完全闭塞经皮冠状动脉介入治疗患者的住院期间结局:系统评价和荟萃分析。
Coron Artery Dis. 2021 Dec 1;32(8):681-688. doi: 10.1097/MCA.0000000000001026.
2
Impact of Chronic Kidney Disease on Chronic Total Occlusion Revascularization Outcomes: A Meta-Analysis.慢性肾脏病对慢性完全闭塞病变血管重建结局的影响:一项荟萃分析。
J Clin Med. 2021 Jan 23;10(3):440. doi: 10.3390/jcm10030440.
3
Impact of Renal Function on Long-Term Clinical Outcomes in Patients With Coronary Chronic Total Occlusions: Results From an Observational Single-Center Cohort Study During the Last 12 Years.
肾功能对冠状动脉慢性完全闭塞患者长期临床结局的影响:一项过去12年单中心观察性队列研究的结果
Front Cardiovasc Med. 2020 Nov 16;7:550428. doi: 10.3389/fcvm.2020.550428. eCollection 2020.
4
Impact of renal function on the immediate and long-term outcomes of percutaneous recanalization of coronary chronic total occlusions: A systematic review and meta-analysis.肾功能对冠状动脉慢性完全闭塞病变经皮再通术近期及远期预后的影响:一项系统评价和荟萃分析
Int J Cardiol. 2020 Oct 15;317:200-206. doi: 10.1016/j.ijcard.2020.05.067. Epub 2020 May 26.
5
Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions.慢性完全闭塞病变经皮治疗中对比剂肾病的评估
Interv Med Appl Sci. 2019 Jun;11(2):95-100. doi: 10.1556/1646.11.2019.15.
6
Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Renal Dysfunction.肾功能不全患者慢性完全闭塞经皮冠状动脉介入治疗的结果。
Am J Cardiol. 2020 Apr 1;125(7):1046-1053. doi: 10.1016/j.amjcard.2019.12.045. Epub 2020 Jan 8.
7
One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry.当代经皮冠状动脉介入治疗后肾功能不全患者的一年临床结局:来自多中心登记处的数据。
Clin Res Cardiol. 2020 Jul;109(7):845-856. doi: 10.1007/s00392-019-01575-y. Epub 2019 Dec 2.
8
Recanalization of Chronic Total Occlusions in Patients With vs Without Chronic Kidney Disease: The Impact of Contrast-Induced Acute Kidney Injury.慢性完全闭塞病变患者与非慢性肾脏病患者的再通:对比剂诱导急性肾损伤的影响。
Can J Cardiol. 2018 Oct;34(10):1275-1282. doi: 10.1016/j.cjca.2018.07.012. Epub 2018 Jul 19.
9
In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.慢性肾脏病患者慢性完全闭塞性经皮冠状动脉介入治疗的院内结局
J Invasive Cardiol. 2018 Nov;30(11):E113-E121. Epub 2018 Sep 15.
10
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.左主干血运重建经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗慢性肾脏病患者: EXCEL 试验。
J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.